Consensus Waters Corporation Borsa Italiana

Stocks

1WAT

US9418481035

Advanced Medical Equipment & Technology

End-of-day quote Borsa Italiana 2026-09-29			5-day change	1st Jan Change
390.00 ^EUR	+1.99%		+4.61%	+20.00%

10-01	Guggenheim Adjusts Price Target on Waters to $490 From $440, Keeps Buy Rating	MT
09-23	Waters Corporation Presents at U.S. All Stars Conference, Sep-23-2026 11:00 AM

da2afe1e009e5a46f.cFgikN6LdFAcsat8t_b3TZREs8c5pz47WibFo2dR3Zo.PwlBqJrZAwRV65wb2YaeCv8MgbV15GQWaEiB4TM8sawSMHfmrLgGEVnczA~abfd4f17235e6c203ffb939a2c6fe564

Analysts' recommendations: Waters Corporation

10-01	Guggenheim Adjusts Price Target on Waters to $490 From $440, Keeps Buy Rating	MT
09-21	Goldman Sachs Adjusts Price Target on Waters to $515 From $465, Maintains Buy Rating	MT
09-09	UBS Upgrades Waters to Buy From Neutral, Adjusts Price Target to $490 From $375	MT
09-03	Baird Adjusts Price Target on Waters to $456 From $434, Keeps Outperform Rating	MT
09-01	HSBC Adjusts Price Target on Waters to $455 From $450, Maintains Buy Rating	MT
08-27	Waters Shares Rise After Piper Sandler Upgrade	MT
08-27	Piper Sandler Upgrades Waters to Overweight From Neutral, $480 Price Target	MT
08-27	Analyst recommendations: Block, Celsius, Crowdstrike, Gitlab, Nvidia…
08-24	Waters' Q4 Guide Conservative, 2027 Growth Could Reach High Single Digits, RBC Says	MT
08-05	Goldman Sachs Adjusts Waters Price Target to $465 From $425	MT
08-05	JPMorgan Adjusts Waters Price Target to $400 From $370	MT
08-05	Wells Fargo Adjusts Waters Price Target to $400 From $370	MT
08-05	Stifel Nicolaus Adjusts Waters Price Target to $420 From $380	MT
08-05	RBC Capital Adjusts Waters Price Target to $475 From $435, Maintains Outperform Rating	MT
08-05	Deutsche Bank Adjusts Waters Price Target to $400 From $380, Maintains Hold Rating	MT
08-05	Barclays Adjusts Price Target on Waters to $460 From $425, Maintains Overweight Rating	MT
08-05	Evercore ISI Adjusts Price Target on Waters to $420 From $410, Maintains Outperform Rating	MT
08-05	Leerink Partners Adjusts Price Target on Waters to $450 From $420, Maintains Outperform Rating	MT
08-05	Bernstein Adjusts Price Target on Waters to $450 From $435, Maintains Outperform Rating	MT
08-05	Jefferies Adjusts Price Target on Waters to $455 From $450, Maintains Buy Rating	MT
08-05	TD Cowen Upgrades Waters to Buy From Hold, Adjusts Price Target to $475 From $408	MT
07-15	TD Cowen Adjusts Price Target on Waters to $408 From $385, Keeps Hold Rating	MT
07-14	Goldman Sachs Adjusts Price Target on Waters to $425 From $380, Maintains Buy Rating	MT
07-13	Baird Adjusts Price Target on Waters to $418 From $387, Maintains Outperform Rating	MT
07-09	Morgan Stanley Adjusts Price Target on Waters to $390 From $350	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	THERMO FISHER SCIENTIFIC, INC.					-3.29%
	DANAHER CORPORATION					+4.92%
	INTUITIVE SURGICAL, INC.					+17.14%
	BOSTON SCIENTIFIC CORPORATION					+39.75%
	EDWARDS LIFESCIENCES CORPORATION					+16.96%
	AGILENT TECHNOLOGIES, INC.					+1.68%
	SIEMENS HEALTHINEERS AG					+19.89%
	VEEVA SYSTEMS INC.					+4.15%
	WATERS CORPORATION					+1.67%
	Average					+11.43%
	Weighted average by Cap.					+8.33%